CAMP4 Therapeutics Corporation Common Stock (CAMP) is a publicly traded Healthcare sector company. As of September 23, 2026, CAMP trades at $4.15 with a market cap of $261.68M and a P/E ratio of -1.80. CAMP moved +0.00% today. Year to date, CAMP is -32.30%; over the trailing twelve months it is +50.91%. Its 52-week range spans $1.31 to $7.75. Analyst consensus is strong buy with an average price target of $9.75. Rallies surfaces CAMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CAMP, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $4.15 |
| Market Cap | $261.68M |
| P/E Ratio | -1.80 |
| EPS | $-2.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.75 |
| 52-Week Low | $1.31 |
| Volume | 120.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.22M |
| Net Income | $-107.24M |
| Gross Margin | 0.00% |
5 analysts cover CAMP: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.75.